中医药在未来医学中的角色及如何全球化?
郑永齐 - 化学进展, 2009 - manu56.magtech.com.cn
… differences are having an influence on medical practice today. The impact of“pharmacogenetics…
by the same or different natural products, and interaction among different pathways of …
by the same or different natural products, and interaction among different pathways of …
β1 肾上腺素受体与CYP2D6 基因多态性对美托洛尔抗高血压治疗的药代动力学和药效学影响
J LIU, Z LIU, Y LIU, Z TAN, D HU, Z LI… - 中国临床药理学 …, 2007 - manu41.magtech.com.cn
… Pharmacogenomics is a rapidly emerging field that aims to … and providing a stronger
scientific basis for optimizing drug … to pharmacokinetics and pharmacodynamics difference of …
scientific basis for optimizing drug … to pharmacokinetics and pharmacodynamics difference of …
[HTML][HTML] 基因多态性与他汀类药物疗效相关性研究进展
付真彦 - Advances in Clinical Medicine, 2023 - hanspub.org
… Abstract: Genetic variation leads to individual differences in pharmacokinetics and
pharmacodynamics, which may affect the response to therapeutic drugs. Although some studies …
pharmacodynamics, which may affect the response to therapeutic drugs. Although some studies …
振源胶囊对辛伐他汀及其活性代谢物在大鼠体内的药动学影响
袁叶, 于博, 张学琴, 李亚男, 王淑梅 - 中国药学(英文版), 2020 - jcps.bjmu.edu.cn
… the potential pharmacokinetic interaction between ginsenoside … , such as the species
differences in absorption and metabolism … in the cholesterol and pharmacogenetics study cohort. …
differences in absorption and metabolism … in the cholesterol and pharmacogenetics study cohort. …
Mechanism of Fuzheng Kang'ai Formula (扶正抗癌方) Regulating Tumor Microenvironment in Non-Small Cell Lung Cancer
Y Tian, S Fu, B Li, L Yuan, Z Bing - Chinese journal of integrative medicine, 2022 - Springer
… of immunoinvasive components in 22 different tumors by … through network pharmacology
and biological information, and … not change the expression by interaction with molecule of CM…
and biological information, and … not change the expression by interaction with molecule of CM…
红参水提液对大鼠体内阿司匹林代谢物的药代动力学影响
薛宇涛, 谭宁, 喻刚艳, 谭丽, 陆洋 - Chinese Medical Sciences …, 2018 - cmsj.cams.cn
… The differences between groups were determined by two … In recent years, some
pharmacokinetic interactions between … a combination of pharmacogenomics and metabolomics …
pharmacokinetic interactions between … a combination of pharmacogenomics and metabolomics …
[HTML][HTML] 托莫西汀在注意力缺陷多动障碍患儿中的精准药学研究: CYP2D6 基因检测和治疗药物监测
符迪, 郭宏丽, 胡雅慧, 陈峰 - Chinese Journal of Contemporary …, 2023 - ncbi.nlm.nih.gov
… its safety and efficacy show significant differences in the pediatric population. This article
reviews the genetic factors influencing the pharmacokinetic differences of atomoxetine from the …
reviews the genetic factors influencing the pharmacokinetic differences of atomoxetine from the …
[HTML][HTML] 抗抑郁药物的体内代谢研究进展
张峰, 秦雪梅, 杜冠华, 高晓霞 - 药学学报, 2017 - html.rhhz.net
… clinical use and the interactions have been already identified between enzymes and
antidepressants. This review focuses on drug metabolism and the interaction for CYP450 enzymes. …
antidepressants. This review focuses on drug metabolism and the interaction for CYP450 enzymes. …
文拉法辛相关PK-PD 关系及影响因素研究进展
王鑫, 邬国栋, 安明, 李刚… - 中国临床药理学与治疗 …, 2023 - manu41.magtech.com.cn
… -release formulations using different release mechanisms: … and the potential of pharmacokinetic
interactions: Doxepin but … Precision medicine using pharmacogenomic panel-testing: …
interactions: Doxepin but … Precision medicine using pharmacogenomic panel-testing: …
[PDF][PDF] 慢性肾衰高磷血症诱导的血管钙化与心血管疾病的相关性及防治进展
赵璐璐, 邢海燕, 王胜男, 高原… - 中国药理学与毒理学 …, 2019 - cjpt.magtechjournal.com
… METHODS Our research use phylogenetic analysis of different cyto⁃ chrome P450
monooxygenases (P450s) related to the biosynthesis of polygala saponin aglycone, we found that …
monooxygenases (P450s) related to the biosynthesis of polygala saponin aglycone, we found that …